ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Shareholders’ equity 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) shareholders’ equity at each fiscal year-end, per SEC filings.
$218.8MFY2025 · since FY2017: -$224.6M → $218.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $218.8M | +7.9% |
| FY2024 | $202.7M | -34.3% |
| FY2023 | $308.4M | -33.6% |
| FY2022 | $464.2M | -23.2% |
| FY2021 | $604.0M | -18.7% |
| FY2020 | $743.3M | +30.2% |
| FY2019 | $571.0M | +321.2% |
| FY2018 | -$258.1M | -14.9% |
| FY2017 | -$224.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice